Atovaquone and quinine anti-malarials inhibit ATP binding cassette transporter activity

The feline bile salt export pump: a structural and functional comparison with canine and human Bsep/BSEP

(2013) Cyrina D van Beusekom et al.   BMC Veterinary Research

Localization of breast cancer resistance protein (Bcrp) in endocrine organs and inhibition of its transport activity by steroid hormones

(2012) Anita C. A. Dankers et al.   CELL AND TISSUE RESEARCH

Effects of Ritonavir-Boosted Lopinavir on the Pharmacokinetics of Quinine

(2012) M M Nyunt et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Interaction of Digitalis-Like Compounds with P-Glycoprotein

(2012) Elnaz Gozalpour et al.   TOXICOLOGICAL SCIENCES

Malaria therapy in HIV: drug interactions between nevirapine and quinine

(2011) A Uriel et al.   INTERNATIONAL JOURNAL OF STD & AIDS

Potential of novel antiretrovirals to modulate expression and function of drug transporters in vitro

(2011) N. C. L. Zembruski et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Marked increase in etravirine and saquinavir plasma concentrations during atovaquone/proguanil prophylaxis

(2011) Chiara Tommasi et al.   MALARIA JOURNAL

Lower atovaquone/proguanil concentrations in patients taking efavirenz, lopinavir/ritonavir or atazanavir/ritonavir

(2010) Matthijs Van Luin et al.   AIDS

Interaction Potential of Etravirine with Drug Transporters AssessedIn Vitro

(2010) Nadine Cécile Luise Zembruski et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effects of concurrent administration of nevirapine on the disposition of quinine in healthy volunteers

(2010) Julius O. Soyinka et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Pharmacokinetic interactions between ritonavir and quinine in healthy volunteers following concurrent administration

(2009) Julius O. Soyinka et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Clinical Pharmacokinetics and Pharmacodynamics of Etravirine

(2009) Monika Schöller-Gyüre et al.   CLINICAL PHARMACOKINETICS

Quinine monotherapy for treating uncomplicated malaria in the era of artemisinin-based combination therapy: an appropriate public health policy?

(2009) Adoke Yeka et al.   LANCET INFECTIOUS DISEASES

Artemisinin Resistance inPlasmodium falciparumMalaria

(2009) Arjen M. Dondorp et al.   NEW ENGLAND JOURNAL OF MEDICINE

Raltegravir: The first HIV integrase inhibitor

(2008) Jennifer Cocohoba et al.   CLINICAL THERAPEUTICS

Preventing malaria in travellers

(2008) David G Lalloo et al.   BMJ-British Medical Journal

The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane

(2007) M. Huls et al.   KIDNEY INTERNATIONAL